Molecule intelOpportunity: Moderate0Underserved

Human Serum Albumin

3 brands · 2 companies · product forms

Opportunity snapshot

Launch attractiveness
39
Market saturation
5
Price room
22
Regulatory risk
0
3
brands
2
companies
Rs 7,463.86
median price
3
price points
1.9x
price spread
90
confidence %

Who competes here

Top companies by brand count — concentrated market · leader share 67%

2 brands · 67%
1 brands · 33%

Price room

Across observed sources and strengths
CheapestRs 7,463.86
MedianRs 7,463.86
Most expensiveRs 14,181.34
Spread1.9×
Sources: DRAP-official

max/min price ratio 1.90x across 3 trusted points (Rs 7463.86-14181.34). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(40) + 25% price-variation(22) + 20% low-competition(95) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

2 canonical companies and 3 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1.90x across 3 trusted points (Rs 7463.86-14181.34). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.